Erytech Pharma S.A.: ERYTECH Provides Business and Financial Update for the First Quarter of 2023
ERYTECH Provides Business and Financial Update for the First Quarter of 2023 Combination with Pherecydes, intending to create a global leader in extended phage therapies to target antimicrobial
Source: finanznachrichten.de